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Abstract 
Objective: To evaluate the effects of aquatic exercise therapy on gait variability and 
disability compared to usual care for people with Parkinson’s disease (PD). 
Design: Single-blind randomized control trial (RCT). 
Setting: A community based hydrotherapy pool in Ireland. 
Participants: Twenty one individuals with PD (Hoehn-Yahr Stages I-III). 
Interventions:  Participants were randomly assigned to either an aquatic exercise therapy 
group (45 minutes, twice a week for 6 weeks) or a control group that received usual care. 
Main Outcome Measure(s): The primary outcome measure was gait variability as measured 
using a Coda CX1 motion capture system. Secondary outcomes were quality of life measured 
on the Parkinson’s Disease Questionnaire-39, freezing of gait and motor disability quantified 
by the Unified Parkinson Disease Rating Scale (UPDRS III). Feasibility was evaluated by 
measuring safety, adverse events and participant satisfaction. 
Results: People in the aquatic therapy group and control group showed similar small 
improvements in gait variability. The aquatic therapy group showed greater improvements in 
disability than the control group (P<0.01). No differences between groups or over time were 
identified for freezing of gait or quality of life. Aquatic therapy sessions were safe and 
enjoyable with no adverse events. 
Conclusions: Aquatic therapy appears feasible and safe for some people in the early stages 
of Parkinson’s disease. 
Keywords: Aquatic therapy; Parkinson’s disease; gait; rehabilitation; exercise; 
physiotherapy.
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Introduction 
Aquatic exercise therapy for people with Parkinson’s disese (PD) has become a recent 
focus of attention, given emerging evidence that physical activity has the potential to 
be both enjoyable and have neuroprotective effects. 1,2 Parkinson’s disease is 
associated with impairments of movement, especially a reduction in step length and 
gait speed. 3,4 Freezing of gait (FOG) also occurs in up to half of individuals with PD. 
5,6 These gait disorders are associated with increased falls risk with more than 60% of 
people with PD experiencing a fall every year. 7,8 Falls are associated with negetive 
physical and psychological consequences including physical injuries, loss of 
independence, fear of falling and sometimes the need for residential care. 9,10 
 
Exercise, physical activity and physiotherapy are core elements of a comprehensive 
rehabilitation program, alongside medical management of PD. 7,11 People with PD are 
encouraged to maintain adequate levels of physical activity throughout the course of 
the disease and to try different forms of exercise over time, to maintain long-term 
exercise participation. 12,13 Aquatic therapy is one form of exercise for people with 
early PD, alongside strategy training, 14 progressive resistance strength training, 7,8 
cycling, 15 tai chi, 16 therapeutic dancing 17,18 and walking programs. 19,20 Aquatic 
therapy enables some people with PD to move more easily while reducing the fear of 
falling. 21,22 Aquatic therapy can also improve balance and functional mobility in 
some individuals with PD. 22-24 The current evidence to support the use of aquatic 
therapy to improve gait in adults with neurological conditions including PD is mainly 
derived from small pilot trials. 25,26 The mixed outcomes of previous studies appear 
related to the variability in intensity and dose of the aquatic therapy, sample 
characteristics and the outcome measures used to assess change.  
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The assessment of gait variability is recommended as research has shown a strong 
link between increased variability of gait and falls risk in people with PD. 27 Gait 
variability is a loss of consistency in the production of a steady, rhythmic gait. 27,28 
Measuring variability using three-dimensional gait analysis enables sensitive and 
reliable quantification of changes in gait performance over time. 29,30  
 
The primary aim of this study was to evaluate the effects of a six-week aquatic 
therapy program compared to usual care on gait variability, motor disability, freezing 
and health related quality of life in people with mild-moderately severe PD. We 
hypothesized that, compared to a group that received usual care, the aquatic exercise 
therapy group would show reduced variability in step length, improved motor 
disability, less freezing and improved quality of life. We also predicted that aquatic 
therapy would be viable and safe for people with PD.  
 
Method 
Participants 
A sample of convenience of 21 participants (14 men, 7 women; mean age ± SD, 71.42 
± 4.9 years) with idiopathic PD, who were deemed eligible to partake in the study by 
their chartered physiotherapist or specialist PD nurse were recruited. Volunteers 
received an information leaflet about the study and were asked to provide written 
informed consent prior to participating in the study. Recruitment took place from 
March to May 2015. All volunteers lived in the Munster region of Ireland. Ethics 
approval was received from the Irish Health Service Executive, Hospital Scientific 
Research Ethics Committee (ethics number 014/15). 
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Inclusion criteria were a diagnosis of idiopathic PD according to the UK Brain Bank 
Criteria 31 confirmed by a neurologist; Hoehn and Yahr stage I-III; stable medication 
status over the past three months. 32 Participants were required to be able to walk 10 
meters three times, without assistance. 14 They were excluded if they had 
contraindications to aquatic therapy including cardiovascular or pulmonary 
conditions, 22 previous history of deep brain stimulation 7 or any musculoskeletal 
condition that affected their ability to participate in the exercise group. 26 
 
Twenty-one participants were randomized and allocated into two groups: the 
physiotherapy treatment group (n=11) who had aquatic therapy and usual care, and 
the control group (n=10) who continued with their usual care involving medication 
alone (table 1). Randomization was carried out using sequentially numbered sealed 
envelopes and this procedure was conducted by a third party. Opaque envelopes were 
used to conceal allocation. All participants were blinded to group allocation. 
 
Assessments 
Assessments took place one week before the six-week aquatic or control intervention 
(T1) and one week after intervention completion (T2). All assessments were carried 
out by a trained physiotherapist (LC). To minimise performance variability due to the 
effects of medication, participants were assessed at the same time of the day,1 and 2.5 
hours after their last medication dose (‘on’ medication phase). 33  Participants in both 
groups were instructed to continue with their usual care and advised not to change 
their typical exercise routine. Each participant was asked to inform the 
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physiotherapist running the group of any changes to their medication or exercise 
habits throughout the six weeks of the trial.  
 
Outcome Measures 
A dual CODA CX1® motion capture system (Charnwood Dynamic Ltd., 
Leceistershire, UK) was used to analyse three-dimensional (3-D) gait and measure the 
primary outcome measure. This 3-D system uses optical sensors fixed onto parallel 
rigid frames to detect infrared light signals which were consecutively pulsed at a 
sampling rate of 200 Hz from the markers positioned at anatomical landmarks on the 
lower body. 34 In accordance with previous research 35 20 active LED markers were 
positioned on the pelvis and lower body segments bilaterally. The spatiotemporal gait 
variables measured were step length (distance between two consequtive footprints), 
step time (timing of the gait cycle for each step) and step width (distance between the 
medio-lateral ankle joint centers). 36,37 Terminal swing end (TSE), initial contact (IC) 
and toe off (TO), were selected manually within Odin softwear (version 1.01.xx) 
using standardised definitions for the gait events. 38,39 Data were exported to SPSS© 
version 22 for further analaysis. 
 
Procedure 
 Following a gait familarisation trial, participants were instructed to walk at their 
“comfortable walking pace”, for a minimum of 10 trials on a 10 meter walkway. 36 
They were instructed to take rest breaks as required between each trial. Steps recorded 
during each test were combined across trials with a minimum of 60 steps (30 steps on 
the left and 30 steps on the right). 36 Fifty or more steps is suggested as optimal when 
calculating gait variability, 36,40 with 10 or more gait trials recommended. 35 The 
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standard deviations for left and right steps were calculated separately and then 
combined to determine gait variability. 36 The combined standard deviation was 
determined by calculating the square root of the mean variance of the left and right 
steps. 36 
 
For the secondary outcome measures, health-related quality of life was quantified by 
the Parkinson’s Disease Questionnaire-39 (PDQ-39). 41 Severity of PD was 
categorised using the Unified Parkinson’s Disease Rating Scale (UPDRS) motor 
subsection III. 42 Freezing was assessed using a six point FOG questionnaire. 43 These 
tools have been found to be both valid and reliable measures 44-46 and were used in 
previous studies investigating the effects of aquatic therapy on people with PD. 32 
Demographic details such as age, disease duration, weight and height were also 
recorded for each participant.  
 
The feasibility of implementing the aquatic therapy intervention was also assessed by 
recording adverse events such as falls, extreme fatigue or changes in PD symptoms 
throughout the six-week intervention phase. We also quantified levels of recruitment, 
attendance and attrition rates. An exit questionnaire 47 captured the experiences and 
viewpoints of participants. The questionnaire incorporated a five point Likert scale to 
examine changes in health and wellbeing in the participants following aquatic therapy 
intervention. 48 
 
Intervention 
Participants in the intervention group attended aquatic therapy (two 45 minute 
sessions each week for six weeks) in a local hydrotherapy pool which was 12 meters 
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long and six meters wide with a graded depth, varying from 0.6 meters to 1.30 meters. 
The water temperature was set at 32°C and air temperature set at 31°C. A trained 
lifeguard was present on the pool deck at all times. Aquatic therapy was delivered by 
a physiotherapist with eight years post-graduate experience in aquatic therapy. 
Aquatic therapy intervention occurred during the period from May to October 2015. 
 
Defining the optimal intensity for aquatic gait training was determined from first 
principles as there was no standard measure for evaluating intensity of gait training in 
water for people with PD. 15  Each session comprised a cardiovascular and stretching 
warm-up for 10 minutes, followed by 25 minutes of specific gait training exercises 
based on recommendations from guidelines recently published in the European 
Physiotherapy Guideline for Parkinson’s disease 11 and a 10 minute cool down 
(Appendix A). Many of the water-based exercises followed a water specific therapy 
(WST) approach as outlined in Lambeck and Gamper. 49 Exercises were progressed 
according to individual ability by increasing the numbers of repetitions, the period of 
aerobic training, the amount of resistance, the level of difficulty of a task (such as 
walking with or without fins). A written recording of each class was completed by the 
physiotherapist to document each participant’s self-reported performance and the 
Borg Rating of Perceived Exertion (RPE) scale was scored during each session. 50 
Participants were monitored using a 1-10 Borg RPE scale, which was used as a means 
of increasing both the intensity and challenge of the therapeutic protocol. When 
ratings were reported below four (moderate difficulty), a progression was introduced 
following the format outlined in Appendix A.  
 
Statistical Analysis 
Aquatic Exercise Therapy for People with Parkinson’s disease: a Randomized 
Controlled Trial  
Carroll, L.M. et al. 2017 
 10 
Sample size calculations were based on motor disability effect sizes from previous 
studies of people with PD. 23,32 An a-prior sample size calculation, based on UPDRS 
III scores with a 10% drop out rate, 80% power and alpha set at 0.05 showed that we 
needed at least 10 participants in each group.  
 
Preliminary descriptive analyses were generated for all variables to present the 
demographic and clinical characteristics of the groups. We checked to ensure that no 
differences between groups existed for baseline characteristics using independent t-
tests and chi-square analyses. The majority of variables were not normally distributed 
hence Mann-Whitney U-tests were used to determine differences in variables for 
between–subject factors (aquatic therapy versus control) and Wilcoxon signed rank 
tests for within-subject factors (time1 versus time 2). Descriptive statistics included 
the median (Md) and Inter-Quartile Range (IQR) with a P value of <0.05 considered 
to be statistically significant. The Statistical Package for Social Sciences (SPSS©) 
version 22 (SPSS Inc., Chicago, IL, USA) was used for all statistical analyses. 
 
Results  
Of the 21 participants, 11 were randomized into the intervention group with all 
completing the aquatic therapy program. Data from one participant was excluded 
from the final analysis as they received medical intervention for a flare up of 
fibromyalgia symptoms not related to PD just before testing. Ten participants were 
randomized into the control group with the data from two participants excluded prior 
to follow up due to an episode of acute back pain and transportation difficulties 
(Figure 1). Intention to treat analysis using last observation carried forward (LOCF) 
was carried out, including for the UPDRS III.  
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There were no statistically significant differences between groups at baseline 
including for age, disease duration and levodopa equivalent dose (LED) (Table 1.) 
The pre-post test results are provided in Table 2. There were no significant 
differences observed between groups for changes in gait variability over the course of 
therapy (Table 2). Nevertheless, after aquatic therapy, variability was reduced for step 
length (Mdn @T1 = 0.03; Mdn @ T2 = 0.02) and step time (Mdn @T1 = 0.02; Mdn 
@T2 = 0.01). There were no changes in gait variability in the control group over the 
course of the study. 
 
A key finding was a statistically significant improvement in motor disability in the 
aquatic therapy group as shown by improvements in the UPDRS III (P=0.01). The 
effect size was 4.5 between the medians (13-17.5).  Given the report by Shulman et al 
51 this difference in median scores would denote a moderate clinically important 
difference for the UPDRS motor score. There was no difference between groups for 
the quality of life or freezing of gait questionnaires, with small improvements in 
scores observed for both questionnaires in the intervention group only.   
 
Feasibility 
The aquatic therapy was found to be feasible and safe, with no adverse events, 
extreme fatigue or exacerbation of PD symptoms reported. There was no attrition in 
the intervention group although two participants attended 11 of the 12 sessions due to 
medical appointments. There was a 100% attendance recorded for the other 
participants.  
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The results from the exit questionnaire showed the aquatic exercise program to be 
very enjoyable with 90% expressing a strong interest in continuing the classes (Figure 
2). Overall, 70% of participants reported improvements in their walking and 
confirmed that the programme was challenging. Participants enjoyed being 
“challenged” and felt that “progression was evident in the skills thought”. The 
majority of participants reported that walking with the “flippers (fins) was probably 
the most difficult but still beneficial”. Most described the exercises stepping up 
exercises as the most beneficial exercise as it “brought about a sense of achievement 
and confidence in my walking”. When asked which exercises included in the 
programme were least beneficial, most reported that “all exercises had a purpose” 
and were “beneficial.”   
 
Discussion 
This randomised trial showed that aquatic therapy was associated with improvements 
in motor function as measured by the UPDRS III. Aquatic therapy was also feasible 
and safe in this sample of people with mild to moderately severe PD, with no adverse 
events reported. These findings are in agreement with the preliminary international 
trials by Vivas et al 23 and Ayán and Cancela. 32 
 
Contrary to predictions, no significant group differences were found for the gait 
variability in relation to step length, step width or step time. The negligible changes in 
gait variability might have been related to the relatively short intervention period. A 
six week intervention period was chosen based on local usual clinical practice, a 
previous research study in Spain 23 and clinical guideline recommendations. 11 Whilst 
Vivas et al 23 found improvements in postural stability following four weeks of 
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aquatic therapy (45 minutes twice weekly), other studies reporting changes following 
aquatic therapy had interventions between two to five months. 22,25,26,32  
 
Aquatic therapy was challenging and enjoyable for the participants with PD in this 
study. Biomechanically, walking in water may be easier for people with PD due to an 
increased resistance to movement from the drag forces of water along with a 
reduction in actual body weight as a result of buoyancy forces. 24 While the protocol 
used in this program may be adapted for larger controlled trials, further studies 
examining intensity, dose effects and long-term benefits for aquatic therapy in PD are 
warranted. Efforts were made to monitor intensity throughout each class however the 
endurance and fitness levels of the participants were varied at baseline as indicated by 
the Borg RPE scale, which resulted in participants progressing at different rates.  
 
Recruitment of participants was challenging. Over half of the eligible participants 
declined, with an acceptance rate of 48%. Reasons given for not participating 
included an inability to swim, with few reporting a fear of water. This varies from 
other PD aquatic studies 22 32 and may reflect sample characteristics. To increase 
sample sizes, future studies should consider providing the aquatic therapy intervention 
across several centres; as well as offering water confidence sessions, possible 
adopting a Halliwick approach, 49 prior to the commencing the trial.  
 
Study Limitations 
There were some limitations of this trial. Firstly, the small sample size may have 
impacted on the ability to detect significant changes in gait variability. The sample 
size calculation was based on an estimate of the changes reported for the UPDRS as at 
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the time there were no other published studies which directly assessed the effects 
of aquatic therapy on gait variability.  The current study has a small sample size, and 
generates new data that can be used for accurate sample size calculation for future 
studies, including for gait variability. Secondly, although testing occurred at the same 
time of the day, we could not rule out the bias introduced by fluctuations in levodopa 
plasma concentrations. Nevertheless, there were no changes to anti-Parkinson’s 
medication reported between T1 and T2 in each group. While all patients were tested 
and treated during the ‘on’ medication phase, the effect of aquatic therapy during the 
‘off’ state needs to be established. This trial tested people with early to middle stage 
PD and the effects of aquatic therapy on people who are in the more advanced stages 
remains unknown.   
 
Conclusion  
In this small feasibility trial, group aquatic therapy delivered over a six week period 
did not improve gait variability to a greater extent than usual care. Aquatic exercise 
therapy was associated with improvements in motor disability and was safe, enjoyable 
and feasible in the early stages of PD. Prospective large scale randomized long-term 
studies are needed to establish whether group aquatic therapy can have a positive 
influence on gait and wellbeing in people with progressive neurological conditions. 
 
List of abreviations 
PD: Parkinson’s disease. UPDRS III: Unified Parkinson Disease Rating Scale – 
subsection 3. FOG: Freezing of gait. PDQ-39: Parkinson’s Disease Questionnaire. 
WST: water specific therapy. RPE: Rating of Perceived Exertion scale. Md: Median. 
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IQR: Interquartile Range. LOCF: last observation carried forward. LED: levodopa 
equivalent dose. 
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Figure Legends 
Figure 1. Flow diagram of study procedures 
Figure 2. Aquatic group participant feedback 
Questions scored using 5-point Likert scale (1 = strongly agree, 2 = somewhat agree, 
3 = neither agree nor disagree, 4 = somewhat disagree, 5 = strongly agree) 
